| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,519 | 2,136 | 3,090 | 4,293 | | Cost of Revenue | 937 | 1,280 | 3,616 | 2,089 | | | Gross Profit | 582 | 856 | (526) | 2,205 | | | Operating Expenses | | Research Development | 295 | 360 | 331 | 716 | | Selling General and Administrative | 1,742 | 2,116 | 2,647 | 2,389 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 66 | 64 | (1,843) | 727 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,522) | (1,683) | (1,661) | (1,627) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (26) | | Earnings Before Interest And Taxes | (1,522) | (1,683) | (1,661) | (1,654) | | Interest Expense | 97 | 85 | 70 | 24 | | Income Before Tax | (1,619) | (1,768) | (1,731) | (1,678) | | Income Tax Expense | 21 | 43 | 64 | 75 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,640) | (1,811) | (1,795) | (1,753) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,640) | (1,811) | (1,795) | (1,753) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,640) | ($1,811) | ($1,795) | ($1,753) |
|
0.20% Nasdaq 
0.09%
Income Statement
